Clinical trial
Relevance of Isoniazid Dosage in Adults Treated for Tuberculosis
NCT06054334 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire, Amiens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Relevance of Isoniazid Dosage in Adults Treated for Tuberculosis
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2023
- Completion date
- November 6, 2025
- Enrollment
- 112 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.